Bausch + Lomb Corporation(BLCO)Earnings, Financials & Key Ratios

BLCO•NYSE

$16.00

$5.7B mkt cap·Price updated May 6, 2026

SectorHealthcare IndustryMedical Instruments Sub-IndustryDental and vision care devices

AboutBausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.Show more

Revenue$5.1B+6.5%
EBITDA$609M+1.8%
Net Income-$360M-13.6%
EPS (Diluted)-1.02-13.3%
Gross Margin54.75%-10.1%
EBITDA Margin11.94%-4.3%
Operating Margin3.69%+9.0%
Net Margin-7.06%-6.7%
ROE-5.51%-17.1%
ROIC1.24%+14.8%
Debt/Equity0.82+9.2%
Interest Coverage0.44+5.5%

Technical→

BLCO Key Insights

Bausch + Lomb Corporation (BLCO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Trading at only 0.9x book value

✗Weaknesses

✗Profits declining 82.1% over 5 years
✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

BLCO Price & Volume

Bausch + Lomb Corporation (BLCO) stock price & volume — 10-year historical chart

Loading chart...

BLCO Growth Metrics

Bausch + Lomb Corporation (BLCO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years8.38%

3 Years10.62%

TTM7.85%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM39.5%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM39.74%

Return on Capital

10 Years2.26%

5 Years1.91%

3 Years1.38%

Last Year1.58%

BLCO Recent Earnings

Bausch + Lomb Corporation (BLCO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 8/12 qtrs (67%)●Beat Revenue 5/12 qtrs (42%)

Q2 2026Latest

Apr 29, 2026

EPS

$0.08

Est $0.06

+33.3%

Revenue

$1.2B

Est $1.2B

+2.3%

Q1 2026

Feb 18, 2026

EPS

$0.32

Est $0.35

-8.6%

Revenue

$1.4B

Est $1.4B

+1.4%

Q4 2025

Oct 29, 2025

EPS

$0.18

Est $0.16

+12.5%

Revenue

$1.3B

Est $1.4B

-7.4%

Q3 2025

Jul 30, 2025

EPS

$0.07

Est $0.06

+16.7%

Revenue

$1.3B

Est $1.3B

+0.3%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 29, 2026	$0.08vs $0.06+33.3%	$1.2Bvs $1.2B+2.3%
Q1 2026	Feb 18, 2026	$0.32vs $0.35-8.6%	$1.4Bvs $1.4B+1.4%
Q4 2025	Oct 29, 2025	$0.18vs $0.16+12.5%	$1.3Bvs $1.4B-7.4%
Q3 2025	Jul 30, 2025	$0.07vs $0.06+16.7%	$1.3Bvs $1.3B+0.3%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
HSICHenry Schein, Inc.Direct Competitor	8.53B	74.37	22.74	4.03%	3.02%	8.24%	6.71%	0.77
ATRCAtriCure, Inc.Direct Competitor	1.49B	29.44	-122.67	14.88%	-2.14%	-2.43%	3.24%	0.18
LNTHLantheus Holdings, Inc.Direct Competitor	5.59B	85.82	25.17	0.5%	15.15%	20.58%	6.34%	0.00
JNJJohnson & JohnsonProduct Competitor	543.64B	225.59	38.96	4.3%	27.26%	31.69%	3.65%	0.51
ABTAbbott LaboratoriesProduct Competitor	151.59B	87.18	11.41	4.59%	31.88%	27.26%	4.19%	0.32
COOThe Cooper Companies, Inc.Product Competitor	12B	61.25	32.75	5.06%	9.67%	4.83%	3.61%	0.34
HOLXHologic, Inc.Product Competitor	16.97B	76.01	30.53	1.74%	13.18%	10.37%	5.42%	0.52
IARTIntegra LifeSciences Holdings CorporationProduct Competitor	1.03B	13.22	-1.96	1.53%	-30.15%	-47.65%		1.95

Compare BLCO vs Peers

Bausch + Lomb Corporation (BLCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HSIC

Most directly comparable listed peer for BLCO.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare BLCO against a more recognizable public peer.

Peer Set

Compare Top 5

vs HSIC, ATRC, LNTH, JNJ

BLCO Income Statement

Bausch + Lomb Corporation (BLCO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	3.78B	3.41B	3.77B	3.77B	4.15B	4.79B	5.1B	5.21B
Revenue Growth %	-	-9.69%	10.35%	0.08%	10.03%	15.56%	6.47%	7.85%
Cost of Goods Sold	1.33B	1.28B	1.47B	1.52B	1.64B	1.87B	2.31B	2.3B
COGS % of Revenue	35.12%	37.66%	38.96%	40.31%	39.6%	39.07%	45.25%	-
Gross Profit	2.45B▲ 0%	2.13B▼ 13.2%	2.3B▲ 8.0%	2.25B▼ 2.1%	2.5B▲ 11.3%	2.92B▲ 16.6%	2.79B▼ 4.3%	2.91B▲ 0%
Gross Margin %	64.88%	62.34%	61.04%	59.69%	60.4%	60.93%	54.75%	55.86%
Gross Profit Growth %	-	-13.22%	8.04%	-2.13%	11.34%	16.57%	-4.32%	-
Operating Expenses	2.06B	1.87B	1.97B	2.04B	2.37B	2.76B	2.6B	2.6B
OpEx % of Revenue	54.39%	54.72%	52.3%	54.19%	57.26%	57.55%	51.07%	-
Selling, General & Admin	1.38B	1.25B	1.39B	1.48B	1.74B	2.08B	2.23B	2.21B
SG&A % of Revenue	36.58%	36.72%	36.89%	39.23%	41.87%	43.46%	43.8%	-
Research & Development	258M	281M	271M	307M	324M	343M	371M	386M
R&D % of Revenue	6.83%	8.24%	7.2%	8.15%	7.81%	7.16%	7.27%	-
Other Operating Expenses	415M	333M	309M	257M	314M	332M	0	0
Operating Income	396M▲ 0%	260M▼ 34.3%	329M▲ 26.5%	207M▼ 37.1%	130M▼ 37.2%	162M▲ 24.6%	188M▲ 16.0%	308M▲ 0%
Operating Margin %	10.48%	7.62%	8.74%	5.49%	3.14%	3.38%	3.69%	5.91%
Operating Income Growth %	-	-34.34%	26.54%	-37.08%	-37.2%	24.62%	16.05%	-
EBITDA	865M	702M	744M	586M	512M	598M	609M	724M
EBITDA Margin %	22.9%	20.57%	19.76%	15.55%	12.35%	12.48%	11.94%	13.9%
EBITDA Growth %	-	-18.84%	5.98%	-21.24%	-12.63%	16.8%	1.84%	37.38%
D&A (Non-Cash Add-back)	469M	442M	415M	379M	382M	436M	421M	416M
EBIT	467M	290M	318M	219M	117M	165M	188M	308M
Net Interest Income	1M	3M	0	-140M	-268M	-384M	-419M	-421M
Interest Income	1M	3M	0	6M	15M	15M	12M	13M
Interest Expense	0	0	0	146M	283M	399M	431M	434M
Other Income/Expense	3M	30M	-11M	-134M	-296M	-396M	-505M	-509M
Pretax Income	399M▲ 0%	290M▼ 27.3%	318M▲ 9.7%	73M▼ 77.0%	-166M▼ 327.4%	-234M▼ 41.0%	-317M▼ 35.5%	-201M▲ 0%
Pretax Margin %	10.56%	8.5%	8.45%	1.94%	-4%	-4.88%	-6.21%	-3.86%
Income Tax	96M	307M	125M	58M	82M	71M	35M	10M
Effective Tax Rate %	24.06%	105.86%	39.31%	79.45%	-49.4%	-30.34%	-11.04%	-4.98%
Net Income	298M▲ 0%	-18M▼ 106.0%	182M▲ 1111.1%	6M▼ 96.7%	-260M▼ 4433.3%	-317M▼ 21.9%	-360M▼ 13.6%	-219M▲ 0%
Net Margin %	7.89%	-0.53%	4.83%	0.16%	-6.27%	-6.62%	-7.06%	-4.21%
Net Income Growth %	-	-106.04%	1111.11%	-96.7%	-4433.33%	-21.92%	-13.56%	39.5%
Net Income (Continuing)	303M	-17M	193M	15M	-248M	-305M	-352M	-211M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	73M	70M	73M	68M	70M	71M	71M	73M
EPS (Diluted)	0.85▲ 0%	-0.05▼ 105.7%	0.52▲ 1170.0%	0.04▼ 91.8%	-0.74▼ 1824.9%	-0.90▼ 21.6%	-1.02▼ 13.3%	-0.62▲ 0%
EPS Growth %	-	-105.72%	1169.96%	-91.75%	-1824.94%	-21.62%	-13.33%	39.74%
EPS (Basic)	0.85	-0.05	0.52	0.04	-0.74	-0.90	-1.02	-
Diluted Shares Outstanding	350M	350M	350M	350M	350.5M	351.8M	353.8M	355.2M
Basic Shares Outstanding	350M	350M	350M	350M	350.5M	351.8M	353.8M	355.2M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

BLCO Balance Sheet

Bausch + Lomb Corporation (BLCO) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	1.7B	1.65B	1.64B	2.14B	2.74B	2.79B	2.98B	2.78B
Cash & Short-Term Investments	192M	238M	174M	380M	334M	305M	383M	268M
Cash Only	192M	238M	174M	380M	334M	305M	383M	268M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	713M	645M	721M	726M	875M	1.03B	1.22B	1.11B
Days Sales Outstanding	68.88	69	69.9	70.33	77.03	78.17	87.37	79
Inventory	592M	616M	572M	628M	1.03B	1.04B	976M	977M
Days Inventory Outstanding	162.83	174.97	142.32	150.9	228.51	202	154.35	159.12
Other Current Assets	198M	155M	3M	403M	505M	421M	397M	425M
Total Non-Current Assets	9.77B	9.61B	9.19B	9.01B	10.7B	10.68B	11.04B	11B
Property, Plant & Equipment	1.09B	1.26B	1.34B	1.42B	1.5B	1.49B	1.76B	1.79B
Fixed Asset Turnover	3.47x	2.70x	2.82x	2.66x	2.76x	3.23x	2.90x	3.00x
Goodwill	4.55B	4.68B	4.59B	4.51B	4.58B	4.52B	4.76B	4.74B
Intangible Assets	2.85B	2.56B	2.26B	2.06B	3.59B	3.49B	3.28B	3.23B
Long-Term Investments	0	0	0	12M	19M	19M	7M	14M
Other Non-Current Assets	82M	65M	1B	84M	92M	275M	303M	1.21B
Total Assets	11.47B▲ 0%	11.27B▼ 1.8%	10.82B▼ 3.9%	11.14B▲ 3.0%	13.44B▲ 20.6%	13.47B▲ 0.2%	14.02B▲ 4.1%	13.78B▲ 0%
Asset Turnover	0.33x	0.30x	0.35x	0.34x	0.31x	0.36x	0.36x	0.38x
Asset Growth %	-	-1.76%	-3.93%	2.97%	20.62%	0.2%	4.11%	13.47%
Total Current Liabilities	1.03B	909M	1.1B	1.3B	1.58B	1.74B	1.92B	1.82B
Accounts Payable	262M	178M	239M	317M	522M	389M	388M	407M
Days Payables Outstanding	72.06	50.56	59.46	76.17	116.04	75.85	61.36	65.05
Short-Term Debt	16M	18M	28M	51M	57M	40M	77M	39M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0
Other Current Liabilities	573M	544M	356M	732M	709M	1.28B	1.46B	1.37B
Current Ratio	1.64x	1.82x	1.49x	1.65x	1.74x	1.60x	1.55x	1.55x
Quick Ratio	1.07x	1.14x	0.97x	1.16x	1.09x	1.01x	1.04x	1.04x
Cash Conversion Cycle	159.65	193.41	152.75	145.06	189.51	204.32	180.36	173.07
Total Non-Current Liabilities	401M	369M	322M	2.75B	4.94B	5.19B	5.58B	5.51B
Long-Term Debt	0	0	0	2.41B	4.53B	4.74B	5.17B	0
Capital Lease Obligations	77M	83M	92M	92M	87M	120M	125M	125M
Deferred Tax Liabilities	0	0	0	7M	14M	13M	19M	66M
Other Non-Current Liabilities	324M	286M	230M	237M	310M	310M	271M	6.8B
Total Liabilities	1.44B	1.28B	1.42B	4.04B	6.52B	6.92B	7.5B	7.33B
Total Debt	93M	101M	140M	2.55B	4.68B	4.94B	5.37B	39M
Net Debt	-99M	-137M	-34M	2.17B	4.34B	4.63B	4.99B	-229M
Debt / Equity	0.01x	0.01x	0.01x	0.36x	0.68x	0.75x	0.82x	0.82x
Debt / EBITDA	0.11x	0.14x	0.19x	4.36x	9.13x	8.25x	8.82x	0.05x
Net Debt / EBITDA	-0.11x	-0.20x	-0.05x	3.71x	8.48x	7.74x	8.19x	8.19x
Interest Coverage	-	-	-	1.50x	0.41x	0.41x	0.44x	0.71x
Total Equity	10.03B▲ 0%	9.99B▼ 0.4%	9.4B▼ 5.9%	7.1B▼ 24.5%	6.92B▼ 2.5%	6.54B▼ 5.4%	6.52B▼ 0.4%	6.45B▲ 0%
Equity Growth %	-	-0.44%	-5.87%	-24.47%	-2.55%	-5.43%	-0.38%	-3.6%
Book Value per Share	28.66	28.54	26.86	20.29	19.74	18.60	18.43	18.16
Total Shareholders' Equity	9.96B	9.92B	9.33B	7.03B	6.85B	6.47B	6.45B	6.38B
Common Stock	11.01B	10.81B	10.36B	0	0	0	0	0
Retained Earnings	0	0	0	6M	-254M	-571M	-931M	-1B
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	-1.05B	-889M	-1.03B	-1.26B	-1.25B	-1.39B	-1.18B	-1.2B
Minority Interest	73M	70M	73M	68M	70M	71M	71M	73M

BLCO Cash Flow Statement

Bausch + Lomb Corporation (BLCO) cash flow — operating, investing & free cash flow history

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	799M	522M	873M	345M	-17M	232M	283M	283M
Operating CF Margin %	21.15%	15.3%	23.19%	9.16%	-0.41%	4.84%	5.55%	-
Operating CF Growth %	-	-34.67%	67.24%	-60.48%	-104.93%	1464.71%	21.98%	862.25%
Net Income	303M	-17M	193M	15M	-248M	-305M	-352M	-219M
Depreciation & Amortization	469M	442M	415M	379M	382M	436M	421M	416M
Stock-Based Compensation	50M	50M	62M	62M	74M	92M	149M	64M
Deferred Taxes	-39M	97M	116M	-90M	-10M	-10M	-32M	-60.39M
Other Non-Cash Items	56M	9M	59M	-2M	72M	106M	79M	164.63M
Working Capital Changes	-40M	-59M	28M	-19M	-287M	-87M	18M	-28.85M
Change in Receivables	-21M	77M	-107M	-95M	-121M	-227M	-148M	-86.24M
Change in Inventory	-91M	-32M	-15M	-106M	-264M	-147M	38M	28.26M
Change in Payables	78M	-144M	163M	189M	245M	126M	108M	35.86M
Cash from Investing	-186M	-256M	-214M	-215M	-2.11B	-412M	-455M	-466.16M
Capital Expenditures	-180M	-259M	-193M	-175M	-181M	-291M	-349M	-336.06M
CapEx % of Revenue	4.76%	7.59%	5.13%	4.64%	4.37%	6.07%	6.84%	-
Acquisitions	6M	6M	-16M	45M	-1.94B	0	0	7.01M
Investments	-	-	-	-	-	-	-	-
Other Investing	-6M	-6M	0	-45M	14M	-123M	-103M	-25.09M
Cash from Financing	-606M	-232M	-712M	81M	2.08B	178M	225M	172.25M
Debt Issued (Net)	0	0	28M	2.46B	2.12B	201M	249M	203.75M
Equity Issued (Net)	0	0	0	0	0	-12M	0	0
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	-12M	0	-2M
Other Financing	-606M	-232M	-740M	-2.38B	-37M	-11M	-24M	-31.5M
Net Change in Cash	4M▲ 0%	46M▲ 1050.0%	-61M▼ 232.6%	203M▲ 432.8%	-46M▼ 122.7%	-18M▲ 60.9%	81M▲ 550.0%	64M▲ 0%
Free Cash Flow	619M▲ 0%	263M▼ 57.5%	680M▲ 158.6%	170M▼ 75.0%	-198M▼ 216.5%	-59M▲ 70.2%	-66M▼ 11.9%	4.33M▲ 0%
FCF Margin %	16.38%	7.71%	18.06%	4.51%	-4.78%	-1.23%	-1.29%	0.08%
FCF Growth %	-	-57.51%	158.56%	-75%	-216.47%	70.2%	-11.86%	102.58%
FCF per Share	1.77	0.75	1.94	0.49	-0.56	-0.17	-0.19	-0.19
FCF Conversion (FCF/Net Income)	2.68x	-29.00x	4.80x	57.50x	0.07x	-0.73x	-0.79x	-0.02x
Interest Paid	0	3M	0	132M	238M	415M	0	0
Taxes Paid	0	57M	53M	83M	64M	91M	0	0

BLCO Key Ratios

Bausch + Lomb Corporation (BLCO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-0.18%	1.88%	0.07%	-3.71%	-4.71%	-5.51%	-3.37%
Return on Invested Capital (ROIC)	1.97%	2.57%	1.67%	0.95%	1.08%	1.24%	1.24%
Gross Margin	62.34%	61.04%	59.69%	60.4%	60.93%	54.75%	55.86%
Net Margin	-0.53%	4.83%	0.16%	-6.27%	-6.62%	-7.06%	-4.21%
Debt / Equity	0.01x	0.01x	0.36x	0.68x	0.75x	0.82x	0.82x
Interest Coverage	-	-	1.50x	0.41x	0.41x	0.44x	0.71x
FCF Conversion	-29.00x	4.80x	57.50x	0.07x	-0.73x	-0.79x	-0.02x
Revenue Growth	-9.69%	10.35%	0.08%	10.03%	15.56%	6.47%	7.85%

BLCO SEC Filings & Documents

Bausch + Lomb Corporation (BLCO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 29, 2026·SEC

Material company update

Feb 18, 2026·SEC

Material company update

Jan 2, 2026·SEC

10-K Annual Reports

FY 2026

Feb 18, 2026·SEC

FY 2025

Feb 19, 2025·SEC

FY 2024

Feb 21, 2024·SEC

10-Q Quarterly Reports

FY 2026

Apr 29, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Jul 30, 2025·SEC

BLCO Frequently Asked Questions

Bausch + Lomb Corporation (BLCO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Bausch + Lomb Corporation (BLCO) reported $5.21B in revenue for fiscal year 2025. This represents a 38% increase from $3.78B in 2019.

Bausch + Lomb Corporation (BLCO) grew revenue by 6.5% over the past year. This is steady growth.

Bausch + Lomb Corporation (BLCO) reported a net loss of $219.0M for fiscal year 2025.

Dividend & Returns

Bausch + Lomb Corporation (BLCO) has a return on equity (ROE) of -5.5%. Negative ROE indicates the company is unprofitable.

Bausch + Lomb Corporation (BLCO) generated $4.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More BLCO

Bausch + Lomb Corporation (BLCO) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Bausch + Lomb Corporation(BLCO)Earnings, Financials & Key Ratios

BLCO Key Insights

✓Strengths

✗Weaknesses

BLCO Price & Volume

BLCO Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

BLCO Recent Earnings

BLCO Peer Comparison

Compare BLCO vs Peers

vs HSIC

vs JNJ

Compare Top 5

BLCO Income Statement

BLCO Balance Sheet

BLCO Cash Flow Statement

BLCO Key Ratios

BLCO SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

BLCO Frequently Asked Questions

Explore More BLCO

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation